179 related articles for article (PubMed ID: 3283255)
1. Use of an enzyme immunoassay to detect serum IgG antibodies to Haemophilus ducreyi.
Museyi K; Van Dyck E; Vervoort T; Taylor D; Hoge C; Piot P
J Infect Dis; 1988 May; 157(5):1039-43. PubMed ID: 3283255
[TBL] [Abstract][Full Text] [Related]
2. Enzyme immunoassays (EIAs) for the detection of anti-Haemophilus ducreyi serum IgA, IgG, and IgM antibodies.
Roggen EL; Hoofd G; Van Dyck E; Piot P
Sex Transm Dis; 1994; 21(1):36-42. PubMed ID: 8140487
[TBL] [Abstract][Full Text] [Related]
3. Antibody to Haemophilus ducreyi among trucking company workers in Kenya.
Rakwar J; Jackson D; Maclean I; Obongo T; Bwayo J; Smith H; Mandaliya K; Moses S; Ndinya-Achola J; Kreiss JK
Sex Transm Dis; 1997 May; 24(5):267-71. PubMed ID: 9153735
[TBL] [Abstract][Full Text] [Related]
4. Use of an adsorption enzyme immunoassay to evaluate the Haemophilus ducreyi specific and cross-reactive humoral immune response of humans.
Alfa MJ; Olson N; Degagne P; Slaney L; Plummer F; Namaara W; Ronald AR
Sex Transm Dis; 1992; 19(6):309-14. PubMed ID: 1492255
[TBL] [Abstract][Full Text] [Related]
5. Standardization of an enzyme immunoassay for human antibody to Haemophilus ducreyi.
Desjardins M; Thompson CE; Filion LG; Ndinya-Achola JO; Plummer FA; Ronald AR; Piot P; Cameron DW
J Clin Microbiol; 1992 Aug; 30(8):2019-24. PubMed ID: 1500508
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya.
Plummer FA; D'Costa LJ; Nsanze H; Dylewski J; Karasira P; Ronald AR
Lancet; 1983 Dec; 2(8362):1293-5. PubMed ID: 6139629
[TBL] [Abstract][Full Text] [Related]
7. Seroepidemiological studies of Haemophilus ducreyi infection in Ethiopian women.
Duncan ME; Roggen E; Tibaux G; Pelzer A; Mehari L; Piot P
Sex Transm Dis; 1994; 21(5):280-8. PubMed ID: 7817262
[TBL] [Abstract][Full Text] [Related]
8. Clinical and in situ cellular responses to Haemophilus ducreyi in the presence or absence of HIV infection.
King R; Choudhri SH; Nasio J; Gough J; Nagelkerke NJ; Plummer FA; Ndinya-Achola JO; Ronald AR
Int J STD AIDS; 1998 Sep; 9(9):531-6. PubMed ID: 9764937
[TBL] [Abstract][Full Text] [Related]
9. Comparison of enzyme immunoassays for antibodies to Haemophilus ducreyi in a community outbreak of chancroid in the United States.
Chen CY; Mertz KJ; Spinola SM; Morse SA
J Infect Dis; 1997 Jun; 175(6):1390-5. PubMed ID: 9180178
[TBL] [Abstract][Full Text] [Related]
10. Etiology of genital ulcer disease in Dakar, Senegal, and comparison of PCR and serologic assays for detection of Haemophilus ducreyi.
Totten PA; Kuypers JM; Chen CY; Alfa MJ; Parsons LM; Dutro SM; Morse SA; Kiviat NB
J Clin Microbiol; 2000 Jan; 38(1):268-73. PubMed ID: 10618099
[TBL] [Abstract][Full Text] [Related]
11. Use of dot-immunobinding and immunofluorescence assays to investigate clinically suspected cases of chancroid.
Schalla WO; Sanders LL; Schmid GP; Tam MR; Morse SA
J Infect Dis; 1986 May; 153(5):879-87. PubMed ID: 3517183
[TBL] [Abstract][Full Text] [Related]
12. Presumptive specific clinical diagnosis of genital ulcer disease (GUD) in a primary health care setting in Nairobi.
Ndinya-Achola JO; Kihara AN; Fisher LD; Krone MR; Plummer FA; Ronald A; Holmes KK
Int J STD AIDS; 1996; 7(3):201-5. PubMed ID: 8799783
[TBL] [Abstract][Full Text] [Related]
13. Specificity of the immune response to Haemophilus ducreyi.
Brown TJ; Ballard RC; Ison CA
Microb Pathog; 1995 Jul; 19(1):31-8. PubMed ID: 8559038
[TBL] [Abstract][Full Text] [Related]
14. A humoral immune response confers protection against Haemophilus ducreyi infection.
Cole LE; Toffer KL; Fulcher RA; San Mateo LR; Orndorff PE; Kawula TH
Infect Immun; 2003 Dec; 71(12):6971-7. PubMed ID: 14638786
[TBL] [Abstract][Full Text] [Related]
15. Development of a serological test for Haemophilus ducreyi for seroprevalence studies.
Elkins C; Yi K; Olsen B; Thomas C; Thomas K; Morse S
J Clin Microbiol; 2000 Apr; 38(4):1520-6. PubMed ID: 10747137
[TBL] [Abstract][Full Text] [Related]
16. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
Frisk A; Ahmed HJ; Van Dyck E; Lagergård T
Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin M and G antibody response in rabbits after experimental Haemophilus ducreyi infection.
Müller F; Müller KH
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Apr; 268(2):238-44. PubMed ID: 3260705
[TBL] [Abstract][Full Text] [Related]
18. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid.
Afonina G; Leduc I; Nepluev I; Jeter C; Routh P; Almond G; Orndorff PE; Hobbs M; Elkins C
Infect Immun; 2006 Apr; 74(4):2224-32. PubMed ID: 16552053
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya.
MacDonald KS; Cameron DW; D'Costa L; Ndinya-Achola JO; Plummer FA; Ronald AR
Antimicrob Agents Chemother; 1989 May; 33(5):612-4. PubMed ID: 2502065
[TBL] [Abstract][Full Text] [Related]
20. Rapid detection of Haemophilus ducreyi in clinical and experimental infections using monoclonal antibody: a preliminary evaluation.
Karim QN; Finn GY; Easmon CS; Dangor Y; Dance DA; Ngeow YF; Ballard RC
Genitourin Med; 1989 Dec; 65(6):361-5. PubMed ID: 2693334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
